Propagation, Inactivation, and Safety Testing of SARS-CoV-2
Open Access
- 6 June 2020
- Vol. 12 (6), 622
- https://doi.org/10.3390/v12060622
Abstract
In late 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, the capital of the Chinese province Hubei. Since then, SARS-CoV-2 has been responsible for a worldwide pandemic resulting in over 4 million infections and over 250,000 deaths. The pandemic has instigated widespread research related to SARS-CoV-2 and the disease that it causes, COVID-19. Research into this new virus will be facilitated by the availability of clearly described and effective procedures that enable the propagation and quantification of infectious virus. As work with the virus is recommended to be performed at biosafety level 3, validated methods to effectively inactivate the virus to enable the safe study of RNA, DNA, and protein from infected cells are also needed. Here, we report methods used to grow SARS-CoV-2 in multiple cell lines and to measure virus infectivity by plaque assay using either agarose or microcrystalline cellulose as an overlay as well as a SARS-CoV-2 specific focus forming assay. We also demonstrate effective inactivation by TRIzol, 10% neutral buffered formalin, beta propiolactone, and heat.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (P01AI120943, R01AI143292)
This publication has 20 references indexed in Scilit:
- Effective Chemical Inactivation of Ebola VirusEmerging Infectious Diseases, 2016
- Comparison ofβ-Propiolactone and Formalin Inactivation on Antigenicity and Immune Response of West Nile VirusAdvances in Virology, 2015
- Application of a focus formation assay for detection and titration of porcine epidemic diarrhea virusJournal of Virological Methods, 2007
- New low-viscosity overlay medium for viral plaque assaysVirology Journal, 2006
- Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoVJournal of Virological Methods, 2004
- Virus inactivation by nucleic acid extraction reagentsJournal of Virological Methods, 2004
- Stability and inactivation of SARS coronavirusMedical Microbiology and Immunology, 2004
- Principles of selective inactivation of viral genome. VIII. The influence of β-propiolactone on immunogenic and protective activities of influenza virusVaccine, 1993
- Principles of selective inactivation of viral genome. VI. Inactivation of the infectivity of the influenza virus by the action of β-propiolactoneVaccine, 1991
- Antigenicity of beta-propiolactone-inactivated virus vaccines.1955